Metabolic Effects of Antiretroviral Therapy in Women living with HIV/AIDS
DOI:
https://doi.org/10.33448/rsd-v11i1.25409Keywords:
HIV; AIDS; Women; Antiretroviral; Metabolic.Abstract
Cultural inequalities that are harmful to women can potentialize the risk of HIV in this group. The aim of this research was to draw the epidemiological and metabolic profile of women diagnosed with HIV. It consists in a cross-sectional analysis of a cohort study, performed in women living with HIV/AIDS that received antiretroviral therapy (ARV) and that were users of the Specialized Care Service in the municipality of Ponta Grossa – PR, between 2003 and 2018. The analysis was descriptive and the association between the medicines used and the metabolic changes were evaluated with relative risk (RR) and through the chi-squared test. Medical records of 451 women were analyzed: 80,5% were white, 44,4% were married, 88,2% contracted HIV by sexual transmission and 83,1% were heterosexual. There was significant association as a risk factor between the use of Protease Inhibitors (PI) and alterations on HDL cholesterol (RR = 1,70, IC95% 1,32-2,20 and p<0,01) and triglycerides levels (RR = 1,29, IC 95% 1,01-1,65 and p= 0,04). As a protective factor, there was a significant association between Non-nucleoside Reverse Transcriptase Inhibitors (NNRTI) and changes in HDL cholesterol levels (RR = 0,66, IC95% 0,53-0,82 and p<0,01). The study has shown association between ARV and metabolic changes in women, specially PI and NNRTI with HDL cholesterol and triglycerides, suggesting the necessity of other drug options for patients with higher cardiovascular risk.
References
Barros, S. G. & Silva, L. M. V. (2017). A terapia antirretroviral combinada, a política de controle da Aids e as transformações do Espaço Aids no Brasil no Brasil dos anos 1990. Saúde debate, 41(2), 114-28.
Berhane, T., Yami, A., Alemseged, F., Yemane, T., Hamza, L., Kassim, M. & Deribe, K. Prevalence of lipodystrophy and metabolic syndrome among HIV positive individuals on Highly Active Anti-Retroviral treatement in Jimma, South West Ethiopia. (2012). Pan Afr Med, 13:43.
Brasil. Ministério da Saúde (MS), 2019. Boletim Epidemiológico de HIV/AIDS.
Brasil. Ministério da Saúde (MS). Protocolo Clínico e Diretrizes Terapêuticas para Manejo da Infecção pelo HIV em Adultos. 2013.
Brenner, B. G. & Baril, J. G. (2017). Limiting cardiovascular events associated with HIV and antiretroviral therapy. AIDS, 31(18), 2551-53.
Carter, A. J., Bourgeois, S., O’Brien, N., Abelsohn, K., Tharao, W., Greene, S., Margolese, S., Kaida, A., Sanchez, M., Palmer, A. K., Cescon, A., Pokomandy, A. & Loutfy, M. R. (2013). Women-specific HIV/AIDS services: identifying and defining the components of holistic service delivery for women living with HIV/AIDS. J Int AIDS Soc, 16(1), 17433.
Deresz, L. F., Brito, C., Schneider, C. B., Rabito, E. I., Ikeda, M. L. R. & Lago, P. D. (2018). Consumo alimentar e risco cardiovascular em pessoas vivendo com HIV/AIDS. Ciênc Saúde Coletiva, 23(8), 2533-42.
Getahun, Z., Azage, M., Abuhay, T. & Abebe, F. (2020). Comorbidity of HIV, hypertension and diabetes and associated factors among people receiving antiretroviral therapy in Bahir Dar city, Ethiopia. J Comorb, 10.
Gianella, S., Tsibris, A., Barr, L. & Godfrey, C. (2016). Barriers to a cure for HIV in women. J Int AIDS Soc, 19(1), 20706.
Gradidge, P. J. L. & Crowther, N. J. (2017). Review: Metabolic Syndrome in Black South African Women.Ethn Dis, 27(2), 189-200.
Hirigo, A. T. & Tesfaye, D. Y. (2016). Influences of gender in metabolic syndrome and its components among people living with HIV virus usig antiretroviral treatment in Hawassa, southern Ethiopia. BMC Res Notes, 9:145.
I Diretriz Brasileira de Diagnóstico e Tratamento da Síndrome Metabólica. Arq Bras Cardiol, 84(1), 3-28.
Kiama, C. N., Wamicwe, J. N., Oyugi, E. O., Obonyo, M. O., Mungai, J. G., Roka, Z. G. & Mwangi, A. (2018). Prevalence and factors associated with metabolic syndrome in an urban population of adults living with HIV in Nairobi, Kenya. Pan Afr Med J, 29:90.
Martin-Iguacel, R., Negredo, E., Peck, R. & Friis-Moller, N. (2016). Hypertension is a key feature of the metabolic syndrome in subjects aging with HIV. (2016). Curr Hypertens Rep, 18(6).
Msoka, T. F., Guilder, G. P. V., Smulders, Y. M., Furth, M., Bartlett, J. A. & Agtmael, M. A. (2018), Association of HIV-infection antiretroviral treatment and metabolic syndrome with large artery stiffness: a cross-sectional study. BMC Infect Dis, 18:708.
Medronho, R. A., Bloch, K. V., Luiz, R. R. & Werneck, G. L. Epidemiologia. Editora Atheneu.
Muller, E. V. & Gimeno, S. G. A. (2019). Risk factors for cardiovascular disease in HIV/AIDS patients treated with highly active antiretroviral therapy (HAART) in the central southern region of the state of Paraná – Brazil. Ciênc saúde coletiva, 24(5), 1903-14.
Nix, L. & Tien, P. C. (2014). Metabolic Syndrome, Diabetes and Cardiovascular Risk in HIV. Curr HIV/AIDS Rep, 11(3), 271-8.
Orza, L., Bass, E., Bell, E., Crone, E. T., Damji, N., Dilmitis, S., Tremlett, L., Aidarus, N., Stevenson, J., Bensaid, S., Kenkem, C., Ross, G. V., Kudraytseya, E. & Welbourn, A. (2017). In Women’s Eyes: key barriers to Women’s Access to HIV Treatment and a Right-Based Approach to their Sustained Well-Being. Health Hum Rights, 19(2), 155-68.
Osorio-Pinzón, J., Pinzón-Tover, A., Vargas-Plazas, H. I., Barreto-Mora, K., Muñoz-Delgado, D. Y., Santana-Velasco, D., Vanegas-Vanegas, C. & Imbachí-Ramos, J. (2018). Perfil hormonal, metabólico y hematológico en adultos con el Vírus de Inmunodeficiencia Humana. Rev Univ Ind Santander Salud, 50(4), 296-306.
Prosperi, M. C. F., Fabbiani, M., Fanti, I., Zaccarelli, M., Colafigli, M., Mondi, A., D’Avino, A., Borghetti, A., Cauda, R. & Di Giambenedetto, S. (2012). Predictors of first-line antiretroviral therapy discontinuation due to drug-related adverse events in HIV-infected patients: a retrospective cohort study. BMC Infec Dis, 12:296.
Russel, E., Albert, A., Côté, H., Hsieh, A., Nesbitt, A., Campbell, A. R., Maan, E. J., Brophy, J., Pick, N. & Murray, M. (2020). Rate of dyslipidemia higher among women living with HIV: A comparison of metabolic and cardiovascular health in a cohort study aging in HIV. HIV Med, 21(8), 418-28.
Zhang, Y., Sivay, M. V., Hudelson, S. E., Clarke, W., Breaud, A., Wang, J., Piwowar-Manning, E., Agyei, Y., Fogel, J. M., Hamilton, E. L., Selin, A., MacPhail, C., Kahn, K., Gomez-Olive, F. X. l Hughes, J. P., Pettifor, A. & Eshleman, S. H. (2018). Antiretroviral drug use and HIV drug resistance among young women in rural South Africa. J Acquir Immune Defic Syndr, 79(3), 315-22.
Downloads
Published
How to Cite
Issue
Section
License
Copyright (c) 2022 Matheus Alves dos Santos; Erildo Vicente Muller; Camila Marinelli Martins
This work is licensed under a Creative Commons Attribution 4.0 International License.
Authors who publish with this journal agree to the following terms:
1) Authors retain copyright and grant the journal right of first publication with the work simultaneously licensed under a Creative Commons Attribution License that allows others to share the work with an acknowledgement of the work's authorship and initial publication in this journal.
2) Authors are able to enter into separate, additional contractual arrangements for the non-exclusive distribution of the journal's published version of the work (e.g., post it to an institutional repository or publish it in a book), with an acknowledgement of its initial publication in this journal.
3) Authors are permitted and encouraged to post their work online (e.g., in institutional repositories or on their website) prior to and during the submission process, as it can lead to productive exchanges, as well as earlier and greater citation of published work.
